本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

16.20
-0.2400-1.46%
成交量:22.92萬
成交額:374.19萬
市值:9.90億
市盈率:-9.86
高:16.61
開:16.43
低:16.18
收:16.44
52周最高:35.34
52周最低:12.12
股本:6,113.68萬
流通股本:4,252.58萬
量比:0.97
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
淨資產收益率:-10.70%
總資產收益率:-8.80%
市淨率:1.07
市盈率(LYR):-8.83

資料載入中...

2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]